Feb. 19, 2025 – A vaccine for pregnant women that protects babies from respiratory syncytial virus (RSV) appears safe, according to two new studies that give researchers hope for widespread ...

More than one million people aged 75 to 79, or those turning 80 after September 1st, will receive invitations for the RSV jab in the coming days, NHS England announced Monday. This vaccination ...

The postponed ACIP meeting comes barely a week after Robert F. Kennedy, Jr. was confirmed as Secretary of Health and Human ...

The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study. The phase 3 randomized controlled ...

Robust immune responses were observed among healthy and high-risk younger adults who received the Ad26/protein RSV preF vaccine.

Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...

High vaccine uptake shows promise for the prevention of respiratory syncytial virus (RSV) in infants. The rollout of 2 major interventions to prevent severe respiratory syncytial virus (RSV ...

Unlike a vaccine, the immunization provides a ready-made supply of antibody protection to babies without triggering an immune system response. Protection against severe RSV infection begins ...

The U.S. has seen earlier and more intense surges of the flu and RSV this year than is typical, pediatrician Dr. Ryan Fulton notes.

Local health boards invited adults aged 75–79, including those turning 75 before July 2025, to come forward for their free RSV vaccine ahead of the winter. By the end of November 2024 ...